We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Colicin E8
From Proteopedia
(Difference between revisions)
(→Synthesis and release) |
|||
| Line 2: | Line 2: | ||
==Synthesis and release== | ==Synthesis and release== | ||
| + | |||
| + | The ColE8 operon is encoded on a plasmid in the ''E. coli'' cell, and includes the gene encoding [[Im8]], its [[Colicin Immunity Protein]]. When the colicin has been synthesised, the immunity protein binds to the cytotoxic domain, to protect the colicinogenic cell from the killing activity. | ||
==Mechanism of uptake== | ==Mechanism of uptake== | ||
==Killing Activities== | ==Killing Activities== | ||
Revision as of 15:00, 26 February 2011
Colicin E3 is a type of Colicin, a bacteriocin made by E. coli which acts against other nearby E. coli to kill them with its DNase Activity; it digests the host's genome at specific locations, ultimately leading to the death of the cell.
Synthesis and release
The ColE8 operon is encoded on a plasmid in the E. coli cell, and includes the gene encoding Im8, its Colicin Immunity Protein. When the colicin has been synthesised, the immunity protein binds to the cytotoxic domain, to protect the colicinogenic cell from the killing activity.
